Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Julianna Longo

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024
  2. Neeraj Jain, PATH’s Country Director for India, speaks on the role of technology in revolutionizing health care, improving outcomes, and driving medical research in India.
    Published: June 2024
  3. PATH’s Regional Director for Advocacy and Public Policy discusses her critical work advancing policies that improve primary health care outcomes for women and girls.
    Published: May 2024
  4. In this op-ed, Melanie Saville, PATH’s Chief Scientific Officer, unpacks barriers to global progress and shares five game-changing steps that would make a big difference in the push for health equity.
    Published: May 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

957 Item s
957 Item s
    Date
    From
    To
  1. Published: February 2024
    Press Release
  2. Published: February 2024
    Statement
  3. The NDV-HXP-S COVID-19 vaccine produced by Thailand’s Government Pharmaceutical Organization (GPO) has the potential to be an affordable option that advances vaccine supply sustainability and pandemic preparedness.
    Published: January 2024
    Statement
  4. Emergency use of nOPV2 has protected millions against polio. Prequalification will ensure broad, long-term accessibility.
    Published: January 2024
    Announcement
  5. Published: December 2023
    Press Release